The next round of tests and appointments will be in April, so we will update the blog after that round.
Thank you for your continued prayers and support!
The Lantz Family
#carolinestrong
#ftgf
Fresh batch of DFMO!
Parent view of the CT Scan
Nov 2017: Diagnosed with Stage IV high-risk Neuroblastoma. Nov 2017–Apr 2019: Completed standard treatment; NED. Apr 2019–Apr 2021: Completed DFMO clinical trial. Apr 2022: Relapse. Apr 2022–Jun 2023: Completed relapse treatment; NED again. Jun 2023–Jun 2024: High-dose DFMO (compassionate use) clinical trial. Jun 2024: Second relapse. Jul 2025: NED again. Mar 2026: Relapse.
Wednesday, December 2, 2020
CT Scan Results
Caroline had her follow-up CT scan today, and the results where all good! The scan showed no issues with the spot that appeared on her liver during her October scans. She remains NED (no evidence of disease) and will continue taking the clinical trial drug, DFMO, until April 2021.
Subscribe to:
Comments (Atom)